title: Ligustrazine attenuates myocardial ischemia reperfusion injury in rats by activating the phosphatidylinositol 3-kinase/Akt pathway.
authors.forename: Lei
authors.initials: L
authors.lastname: Lv
authors.forename: Qingxin
authors.initials: Q
authors.lastname: Meng
authors.forename: Jun
authors.initials: J
authors.lastname: Xu
authors.forename: Jianbin
authors.initials: J
authors.lastname: Gong
authors.forename: Yan
authors.initials: Y
authors.lastname: Cheng
authors.forename: Shisen
authors.initials: S
authors.lastname: Jiang
mesh_terms: D000818:Animals; D052279:Creatine Kinase, MB Form / Q000097:blood; D004789:Enzyme Activation / Q000187:drug effects; D008315:Malondialdehyde / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology* / Q000473:pathology; D009206:Myocardium / Q000201:enzymology / Q000473:pathology / Q000648:ultrastructure; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D058539:Phosphatidylinositol 3-Kinase / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects*; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D011719:Pyrazines; D008315:Malondialdehyde; D052250:Nitric Oxide Synthase Type III; D013482:Superoxide Dismutase; D058539:Phosphatidylinositol 3-Kinase; D051057:Proto-Oncogene Proteins c-akt; D052279:Creatine Kinase, MB Form; C017953:tetramethylpyrazine